Contraception: latest news

Contraception resources

Contraception features

Contraception news from aidsmap

More news

Contraception news selected from other sources

  • HIV-positive women bear brunt of stigma

    South Africa’s first national HIV stigma survey has found that 7 percent of HIV-positive women surveyed reported being sterilised against their will. About 40 percent said contraception use had been a pre-requisite to accessing antiretroviral (ARV) treatment, contrary to national policy.

    12 June 2015 | Independent Online
  • FDA Asked To Add HIV Warning To Birth Control Label

    Nearly two dozen doctors and scientists have signed off on a citizen petition to the U.S. Food and Drug Administration urging the agency to add language to Pfizer Inc.’s Depo-Provera birth control shot indicating that the shot could increase a woman’s chances of being infected with HIV.

    03 June 2015 | Law 360
  • Tense debate over ethics of trial on link between HIV, contraception

    Thus far, most evidence pertaining to the use of Depo-Provera and the risk of HIV-infection come from observational studies, which can reveal whether two factors are associated with each other, but cannot determine whether one is causing the other to occur. Given this limitation, some scholars are looking to develop a randomised controlled trial, an experimental study that is better at determining cause and effect.

    01 May 2015 | Mail & Guardian
  • S.Africa HIV-positive women forced to sterilise: rights groups

    Doctors at some public hospitals in South Africa have allegedly coerced dozens of HIV-positive women to undergo sterilisation over the past three decades, rights groups said Thursday.

    20 March 2015 | Yahoo News
  • The Latest Study on Depo-Provera and HIV: Far More Complex Than Most Headlines Suggest

    A newly published study is stirring up questions about the relationship between Depo-Provera, and other progestogen-only injectable contraceptives, and the risk of HIV acquisition among HIV-negative women. The study triggered a wave of headlines and tweets that boiled down the complexities and caveats of this analysis into an oversimplified statement: Depo increases women’s risk of HIV by 40 percent.

    14 January 2015 | RH Reality Check
  • Contraceptive injection raises risk of HIV, research warns

    Lancet analysis finds 40% increase in infection risk for women using birth control jab compared with other hormonal methods.

    09 January 2015 | The Guardian
  • PrEP works in women using injectable hormonal contraceptives and in their male sex partners

    Preexposure prophylaxis (PrEP) with tenofovir or tenofovir/emtricitabine proved as effective in women using the injectable hormonal contraceptive depot medroxyprogesterone acetate (DMPA) as in women using no hormonal contraceptive. The same proved true of men whose female sex partners were using DMPA.

    07 January 2015 | International AIDS Society
  • Can Women Living with HIV and Taking Antiretroviral Therapy Use Hormonal Contraceptive Methods?

    An increasingly important issue is whether certain ART regimens are expected to have drug interactions when used with certain hormonal contraceptive methods. In theory, an interaction could affect the efficacy of either medication, or cause side effects or toxicity. If contraceptive efficacy decreases, the chances of contraceptive failure, unintended pregnancy, and the accompanying consequences increase.

    10 December 2014 | K4Health
  • As strategies to prevent HIV and unintended pregnancies evolve, concepts of “multi-purpose technologies” raise a familiar question . . .

    What do women want? While two trials test vaginal rings to fight HIV, market research highlights respondents’ interests in different options.

    14 November 2014 | Science Speaks
  • Dissolving Tampons Deliver HIV Drugs (and Maybe Contraception, Too)

    University of Washington researchers have created a discreet, quick-dissolving tampon out of silk-line fibers to protect women from HIV. The researchers would ideally like to develop a tampon to protect against HIV, herpes, and pregnancy — an all-in-one shield against the risks of sex. This could prove especially useful in developing countries, where women may not have easy access to other kinds of birth control.

    04 November 2014 | Healthline News
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also